ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

27,957Medicare Part D Prescriptions Filled, Including Refills

Rank: 29 out of 2888

$1.55M Total Retail Price of All Prescriptions

Rank: 63 out of 2888

1,066 Patients Receiving at Least One Drug in Part D
67%Patients 65 Years and Older
77% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

30% of this provider’s 1,066 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

4% of this provider’s 19,898 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $67 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
HYDROCODONE-ACETAMINOPHEN 1,715 778 S3 1 4
LISINOPRIL 1,411 1,073 2 3
AMLODIPINE BESYLATE 1,040 777 3 5
SIMVASTATIN 958 733 4 2
FUROSEMIDE 880 699 5 6
DONEPEZIL HCL 572 509 6 26
OMEPRAZOLE 560 445 7 7
LEVOTHYROXINE SODIUM 528 396 8 1
METFORMIN HCL 526 401 9 8
PRAVASTATIN SODIUM 463 374 10 12
HYDROCHLOROTHIAZIDE 455 370 11 15
TRAMADOL HCL 425 288 12 16
GABAPENTIN 406 225 13 13
METOPROLOL TARTRATE 404 295 14 10
POTASSIUM CHLORIDE 365 312 15 14
NEXIUM 348 169 16 19
CARVEDILOL 335 257 17 21
NAMENDA 322 304 18 34
WARFARIN SODIUM 305 227 19 22
ZOLPIDEM TARTRATE 289 113 20 17
LISINOPRIL-HYDROCHLOROTHIAZIDE 277 219 21 28
CARISOPRODOL 250 34 R 22 82
TRAZODONE HCL 235 135 23 43
IBUPROFEN 213 158 24 87
LANTUS 212 173 25 45
CYCLOBENZAPRINE HCL 212 91 R 25 68
CRESTOR 204 161 27 20
LOSARTAN POTASSIUM 203 149 28 18
DIOVAN 195 154 29 35
CITALOPRAM HBR 195 101 29 24
RANITIDINE HCL 194 141 31 56
GLYBURIDE 193 159 R 32 58
CLONIDINE HCL 192 135 33 39
SERTRALINE HCL 190 149 34 27
ATORVASTATIN CALCIUM 184 149 35 9
ESCITALOPRAM OXALATE 184 123 35 62
NOVOLIN 70-30 178 155 37 144
ALLOPURINOL 177 141 38 37
CLOPIDOGREL 174 139 39 30
ATENOLOL 174 139 39 25
QUETIAPINE FUMARATE 173 90 41 66
METOPROLOL SUCCINATE 173 145 41 11
AMOXICILLIN 161 93 43 117
TRIAMTERENE-HCTZ 159 115 44 63
MIRTAZAPINE 156 141 45 54
HUMULIN R 149 139 46 233
LOVASTATIN 148 116 47 41
VERAPAMIL ER 147 126 48 104
SULFAMETHOXAZOLE-TRIMETHOPRIM 140 92 49 88
PROAIR HFA 137 61 50 71
LEVETIRACETAM 132 72 51 103
NOVOLIN R 132 109 51 109
PANTOPRAZOLE SODIUM 131 100 53 33
GLUCAGEN 127 125 54 288
CYMBALTA 120 68 55 44
HYDRALAZINE HCL 118 87 56 59
NIFEDIPINE ER 117 97 57 76
DIVALPROEX SODIUM 114 77 58 100
METOCLOPRAMIDE HCL 112 101 59 116
DIOVAN HCT 111 111 60 61
NAPROXEN 110 84 61 80
PLAVIX 109 93 62 40
GLIMEPIRIDE 108 100 63 36
AZITHROMYCIN 106 46 64 38
PAROXETINE HCL 105 76 65 84
PHENYTOIN SODIUM EXTENDED 104 79 66 128
PROMETHAZINE HCL 102 56 R 67 96
INSULIN SYRINGE 101 72 68 86
DOXAZOSIN MESYLATE 100 88 69 94
AMITRIPTYLINE HCL 98 60 R 70 74
TRAVATAN Z 96 92 71 239
RISPERIDONE 95 72 72 72
NIFEDIAC CC 93 89 73 300
BUSPIRONE HCL 91 83 74 148
KLOR-CON M20 91 86 74 90
GLIPIZIDE 91 79 74 50
DIGOXIN 89 68 77 55
CIPROFLOXACIN HCL 89 61 77 47
EXFORGE 88 79 79 159
MELOXICAM 87 51 80 31
LIPITOR 86 57 81 78
FAMOTIDINE 82 58 82 75
OXYBUTYNIN CHLORIDE 80 44 83 124
ACTOS 76 59 84 108
ADVAIR DISKUS 75 46 85 60
FLUTICASONE PROPIONATE 75 52 85 32
CEPHALEXIN 75 50 85 119
LANTUS SOLOSTAR 74 55 88 92
KLOR-CON M10 73 65 89 118
JANUVIA 71 36 90 48
HYDROXYZINE HCL 71 48 R 90 174
BENAZEPRIL HCL 69 54 92 77
SINGULAIR 69 45 92 85
TRIAMCINOLONE ACETONIDE 68 56 94 145
ABILIFY 67 19 95 172
TAMSULOSIN HCL 67 66 95 29
AMOX TR-POTASSIUM CLAVULANATE 66 38 97 112
PREMARIN 66 30 R 97 129
CARBIDOPA-LEVODOPA 65 63 99 113
OLANZAPINE 65 48 99 137
LEVOFLOXACIN 65 48 99 57
CELEBREX 64 55 102 89
LYRICA 64 44 102 69
PATANOL 63 59 104 237
HUMULIN 70-30 62 49 105 230
ISOSORBIDE MONONITRATE ER 60 56 106 51
MONTELUKAST SODIUM 59 28 107 153
FINASTERIDE 57 49 108 102
LEXAPRO 56 38 109 198
AMLODIPINE BESYLATE-BENAZEPRIL 55 45 110 67
LOSARTAN-HYDROCHLOROTHIAZIDE 55 42 110 46
FLUOXETINE HCL 54 43 112 83
AMIODARONE HCL 53 49 113 167
ETODOLAC 53 20 113 170
MECLIZINE HCL 52 38 115 122
LIDODERM 52 24 115 105
SANTYL 51 49 117 210
LAMOTRIGINE 50 19 118 257
FLUCONAZOLE 50 22 118 199
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 27, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.